nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Budesonide—ulcerative colitis	0.0604	0.256	CbGbCtD
Orlistat—CYP3A4—Methylprednisolone—ulcerative colitis	0.027	0.115	CbGbCtD
Orlistat—CYP3A4—Nicotine—ulcerative colitis	0.0263	0.112	CbGbCtD
Orlistat—CYP3A4—Cholecalciferol—ulcerative colitis	0.0236	0.1	CbGbCtD
Orlistat—CYP3A4—Triamcinolone—ulcerative colitis	0.0205	0.0868	CbGbCtD
Orlistat—LIPF—digestive system—ulcerative colitis	0.0186	0.29	CbGeAlD
Orlistat—CYP3A4—Betamethasone—ulcerative colitis	0.0175	0.0745	CbGbCtD
Orlistat—CYP3A4—Prednisolone—ulcerative colitis	0.0173	0.0735	CbGbCtD
Orlistat—CYP3A4—Hydrocortisone—ulcerative colitis	0.0164	0.0697	CbGbCtD
Orlistat—CYP3A4—Prednisone—ulcerative colitis	0.0163	0.0694	CbGbCtD
Orlistat—CYP3A4—Dexamethasone—ulcerative colitis	0.0102	0.0433	CbGbCtD
Orlistat—PLA2G7—lymphoid tissue—ulcerative colitis	0.00762	0.118	CbGeAlD
Orlistat—DAGLB—liver—ulcerative colitis	0.00694	0.108	CbGeAlD
Orlistat—PNLIP—digestive system—ulcerative colitis	0.00662	0.103	CbGeAlD
Orlistat—PLA2G7—liver—ulcerative colitis	0.00561	0.0871	CbGeAlD
Orlistat—PNLIP—liver—ulcerative colitis	0.00493	0.0766	CbGeAlD
Orlistat—ABHD12—liver—ulcerative colitis	0.00493	0.0766	CbGeAlD
Orlistat—FASN—liver—ulcerative colitis	0.00414	0.0643	CbGeAlD
Orlistat—PLA2G4A—smooth muscle tissue—ulcerative colitis	0.00338	0.0525	CbGeAlD
Orlistat—PLA2G4A—Betamethasone—Budesonide—ulcerative colitis	0.00105	0.131	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Budesonide—ulcerative colitis	0.00105	0.131	CbGdCrCtD
Orlistat—CYP3A4—digestive system—ulcerative colitis	0.000881	0.0137	CbGeAlD
Orlistat—CYP3A4—liver—ulcerative colitis	0.000656	0.0102	CbGeAlD
Orlistat—PLA2G4A—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000537	0.0673	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Hydrocortisone—ulcerative colitis	0.000537	0.0673	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000507	0.0635	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Methylprednisolone—ulcerative colitis	0.000507	0.0635	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Betamethasone—ulcerative colitis	0.000499	0.0625	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Dexamethasone—ulcerative colitis	0.000499	0.0625	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Triamcinolone—ulcerative colitis	0.000487	0.061	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Triamcinolone—ulcerative colitis	0.000487	0.061	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisone—ulcerative colitis	0.000462	0.0579	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisone—ulcerative colitis	0.000462	0.0579	CbGdCrCtD
Orlistat—DAGLB—Hemostasis—MMP1—ulcerative colitis	0.000458	0.002	CbGpPWpGaD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—ulcerative colitis	0.000451	0.0565	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—ulcerative colitis	0.000451	0.0565	CbGdCrCtD
Orlistat—FASN—Metabolism—CHP1—ulcerative colitis	0.000451	0.00198	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—JAK2—ulcerative colitis	0.00043	0.00188	CbGpPWpGaD
Orlistat—FASN—Disease—SEL1L—ulcerative colitis	0.000428	0.00187	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—ulcerative colitis	0.000427	0.00187	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000426	0.00186	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000426	0.00186	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SEL1L—ulcerative colitis	0.000424	0.00185	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000423	0.00185	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—GHRL—ulcerative colitis	0.000423	0.00185	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—GHRL—ulcerative colitis	0.000423	0.00185	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR1—ulcerative colitis	0.000421	0.00184	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCR1—ulcerative colitis	0.000421	0.00184	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—JAK2—ulcerative colitis	0.000414	0.00181	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CALM3—ulcerative colitis	0.000409	0.00179	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CALM3—ulcerative colitis	0.000409	0.00179	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—RELA—ulcerative colitis	0.000401	0.00176	CbGpPWpGaD
Orlistat—FASN—Metabolism—DLD—ulcerative colitis	0.000389	0.00171	CbGpPWpGaD
Orlistat—PNLIP—Disease—SLC11A1—ulcerative colitis	0.000387	0.00169	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000385	0.00169	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000385	0.00169	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	0.000385	0.00169	CbGpPWpGaD
Orlistat—FASN—Disease—LTF—ulcerative colitis	0.000384	0.00168	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL20—ulcerative colitis	0.00037	0.00162	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL20—ulcerative colitis	0.00037	0.00162	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—ulcerative colitis	0.00036	0.00158	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—ADRB2—ulcerative colitis	0.00035	0.00153	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—ADRB2—ulcerative colitis	0.00035	0.00153	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCR1—ulcerative colitis	0.000349	0.00153	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	0.000348	0.00152	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GNA12—ulcerative colitis	0.000347	0.00152	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GNA12—ulcerative colitis	0.000347	0.00152	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAML2—ulcerative colitis	0.000347	0.00152	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—ALB—ulcerative colitis	0.000347	0.00152	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—ALB—ulcerative colitis	0.000347	0.00152	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—ulcerative colitis	0.000342	0.0015	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NFKB1—ulcerative colitis	0.000338	0.00148	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCR2—ulcerative colitis	0.000329	0.00144	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR2—ulcerative colitis	0.000329	0.00144	CbGpPWpGaD
Orlistat—Rash—Budesonide—ulcerative colitis	0.000329	0.000709	CcSEcCtD
Orlistat—Dermatitis—Budesonide—ulcerative colitis	0.000328	0.000708	CcSEcCtD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000328	0.00144	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000328	0.00144	CbGpPWpGaD
Orlistat—Convulsion—Prednisolone—ulcerative colitis	0.000328	0.000706	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000327	0.00143	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000327	0.00143	CbGpPWpGaD
Orlistat—Headache—Budesonide—ulcerative colitis	0.000326	0.000704	CcSEcCtD
Orlistat—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000323	0.000696	CcSEcCtD
Orlistat—DAGLB—Hemostasis—JAK2—ulcerative colitis	0.000323	0.00141	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—JAK2—ulcerative colitis	0.000323	0.00141	CbGpPWpGaD
Orlistat—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000322	0.000694	CcSEcCtD
Orlistat—Alopecia—Betamethasone—ulcerative colitis	0.00032	0.000691	CcSEcCtD
Orlistat—Alopecia—Dexamethasone—ulcerative colitis	0.00032	0.000691	CcSEcCtD
Orlistat—Convulsion—Hydrocortisone—ulcerative colitis	0.00032	0.00069	CcSEcCtD
Orlistat—Diarrhoea—Azathioprine—ulcerative colitis	0.000318	0.000686	CcSEcCtD
Orlistat—Discomfort—Prednisolone—ulcerative colitis	0.000318	0.000686	CcSEcCtD
Orlistat—Angioedema—Triamcinolone—ulcerative colitis	0.000318	0.000685	CcSEcCtD
Orlistat—Haemoglobin—Prednisone—ulcerative colitis	0.000317	0.000684	CcSEcCtD
Orlistat—Angioedema—Methylprednisolone—ulcerative colitis	0.000317	0.000684	CcSEcCtD
Orlistat—Haemorrhage—Prednisone—ulcerative colitis	0.000316	0.000681	CcSEcCtD
Orlistat—Myalgia—Hydrocortisone—ulcerative colitis	0.000314	0.000678	CcSEcCtD
Orlistat—Malaise—Triamcinolone—ulcerative colitis	0.000314	0.000676	CcSEcCtD
Orlistat—Anxiety—Hydrocortisone—ulcerative colitis	0.000313	0.000676	CcSEcCtD
Orlistat—Malaise—Methylprednisolone—ulcerative colitis	0.000313	0.000675	CcSEcCtD
Orlistat—Vertigo—Triamcinolone—ulcerative colitis	0.000312	0.000674	CcSEcCtD
Orlistat—Hypersensitivity—Mesalazine—ulcerative colitis	0.000312	0.000673	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000312	0.000673	CcSEcCtD
Orlistat—Vertigo—Methylprednisolone—ulcerative colitis	0.000312	0.000672	CcSEcCtD
Orlistat—Discomfort—Hydrocortisone—ulcerative colitis	0.000311	0.00067	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—CCR6—ulcerative colitis	0.00031	0.00136	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCR6—ulcerative colitis	0.00031	0.00136	CbGpPWpGaD
Orlistat—Nausea—Budesonide—ulcerative colitis	0.00031	0.000667	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000309	0.000665	CcSEcCtD
Orlistat—Oedema—Prednisolone—ulcerative colitis	0.000309	0.000665	CcSEcCtD
Orlistat—Dizziness—Azathioprine—ulcerative colitis	0.000308	0.000663	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CCL20—ulcerative colitis	0.000306	0.00134	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—ulcerative colitis	0.000306	0.00134	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000304	0.00133	CbGpPWpGaD
Orlistat—Asthenia—Mesalazine—ulcerative colitis	0.000304	0.000656	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—STAT3—ulcerative colitis	0.000304	0.00133	CbGpPWpGaD
Orlistat—Cough—Triamcinolone—ulcerative colitis	0.000303	0.000654	CcSEcCtD
Orlistat—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000301	0.00065	CcSEcCtD
Orlistat—Oedema—Hydrocortisone—ulcerative colitis	0.000301	0.00065	CcSEcCtD
Orlistat—Convulsion—Triamcinolone—ulcerative colitis	0.000301	0.00065	CcSEcCtD
Orlistat—Convulsion—Methylprednisolone—ulcerative colitis	0.000301	0.000648	CcSEcCtD
Orlistat—Pruritus—Mesalazine—ulcerative colitis	0.0003	0.000647	CcSEcCtD
Orlistat—Infection—Hydrocortisone—ulcerative colitis	0.000299	0.000646	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000298	0.000643	CcSEcCtD
Orlistat—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000297	0.0013	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—ADCY5—ulcerative colitis	0.000297	0.0013	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—ADCY5—ulcerative colitis	0.000297	0.0013	CbGpPWpGaD
Orlistat—Myalgia—Triamcinolone—ulcerative colitis	0.000296	0.000638	CcSEcCtD
Orlistat—Vomiting—Azathioprine—ulcerative colitis	0.000296	0.000638	CcSEcCtD
Orlistat—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000296	0.000637	CcSEcCtD
Orlistat—Myalgia—Methylprednisolone—ulcerative colitis	0.000295	0.000637	CcSEcCtD
Orlistat—Anxiety—Methylprednisolone—ulcerative colitis	0.000294	0.000635	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—MAML2—ulcerative colitis	0.000294	0.00129	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAML2—ulcerative colitis	0.000294	0.00129	CbGpPWpGaD
Orlistat—Rash—Azathioprine—ulcerative colitis	0.000293	0.000633	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000293	0.000633	CcSEcCtD
Orlistat—Dermatitis—Azathioprine—ulcerative colitis	0.000293	0.000632	CcSEcCtD
Orlistat—Skin disorder—Hydrocortisone—ulcerative colitis	0.000293	0.000631	CcSEcCtD
Orlistat—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000293	0.000631	CcSEcCtD
Orlistat—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000293	0.000631	CcSEcCtD
Orlistat—Discomfort—Triamcinolone—ulcerative colitis	0.000292	0.000631	CcSEcCtD
Orlistat—Discomfort—Methylprednisolone—ulcerative colitis	0.000292	0.000629	CcSEcCtD
Orlistat—Headache—Azathioprine—ulcerative colitis	0.000291	0.000629	CcSEcCtD
Orlistat—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000291	0.000628	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000291	0.00127	CbGpPWpGaD
Orlistat—Diarrhoea—Mesalazine—ulcerative colitis	0.00029	0.000625	CcSEcCtD
Orlistat—Dry mouth—Triamcinolone—ulcerative colitis	0.000289	0.000624	CcSEcCtD
Orlistat—Angioedema—Dexamethasone—ulcerative colitis	0.000288	0.000622	CcSEcCtD
Orlistat—Angioedema—Betamethasone—ulcerative colitis	0.000288	0.000622	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—GNA12—ulcerative colitis	0.000288	0.00126	CbGpPWpGaD
Orlistat—PNLIP—Disease—CALM3—ulcerative colitis	0.000286	0.00125	CbGpPWpGaD
Orlistat—Immune system disorder—Prednisone—ulcerative colitis	0.000285	0.000615	CcSEcCtD
Orlistat—Malaise—Dexamethasone—ulcerative colitis	0.000284	0.000613	CcSEcCtD
Orlistat—Malaise—Betamethasone—ulcerative colitis	0.000284	0.000613	CcSEcCtD
Orlistat—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000284	0.000612	CcSEcCtD
Orlistat—Oedema—Triamcinolone—ulcerative colitis	0.000284	0.000612	CcSEcCtD
Orlistat—Vertigo—Betamethasone—ulcerative colitis	0.000283	0.000611	CcSEcCtD
Orlistat—Vertigo—Dexamethasone—ulcerative colitis	0.000283	0.000611	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000283	0.00124	CbGpPWpGaD
Orlistat—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000283	0.000611	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000283	0.00124	CbGpPWpGaD
Orlistat—Infection—Triamcinolone—ulcerative colitis	0.000282	0.000608	CcSEcCtD
Orlistat—DAGLB—Hemostasis—IL2—ulcerative colitis	0.000281	0.00123	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL2—ulcerative colitis	0.000281	0.00123	CbGpPWpGaD
Orlistat—Infection—Methylprednisolone—ulcerative colitis	0.000281	0.000607	CcSEcCtD
Orlistat—Dizziness—Mesalazine—ulcerative colitis	0.00028	0.000604	CcSEcCtD
Orlistat—Insomnia—Prednisolone—ulcerative colitis	0.000279	0.000602	CcSEcCtD
Orlistat—Alopecia—Prednisone—ulcerative colitis	0.000279	0.000601	CcSEcCtD
Orlistat—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000278	0.000599	CcSEcCtD
Orlistat—Paraesthesia—Prednisolone—ulcerative colitis	0.000277	0.000597	CcSEcCtD
Orlistat—Mental disorder—Prednisone—ulcerative colitis	0.000276	0.000596	CcSEcCtD
Orlistat—Nausea—Azathioprine—ulcerative colitis	0.000276	0.000596	CcSEcCtD
Orlistat—Skin disorder—Methylprednisolone—ulcerative colitis	0.000275	0.000593	CcSEcCtD
Orlistat—Malnutrition—Prednisone—ulcerative colitis	0.000275	0.000592	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000275	0.000592	CcSEcCtD
Orlistat—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000274	0.000592	CcSEcCtD
Orlistat—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000274	0.00059	CcSEcCtD
Orlistat—FASN—Disease—SLC11A1—ulcerative colitis	0.000274	0.0012	CbGpPWpGaD
Orlistat—Convulsion—Betamethasone—ulcerative colitis	0.000273	0.000589	CcSEcCtD
Orlistat—Convulsion—Dexamethasone—ulcerative colitis	0.000273	0.000589	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CXCR2—ulcerative colitis	0.000273	0.0012	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTGER4—ulcerative colitis	0.000273	0.00119	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTGER4—ulcerative colitis	0.000273	0.00119	CbGpPWpGaD
Orlistat—Insomnia—Hydrocortisone—ulcerative colitis	0.000273	0.000588	CcSEcCtD
Orlistat—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000271	0.000584	CcSEcCtD
Orlistat—Vomiting—Mesalazine—ulcerative colitis	0.000269	0.000581	CcSEcCtD
Orlistat—Myalgia—Betamethasone—ulcerative colitis	0.000269	0.000579	CcSEcCtD
Orlistat—Myalgia—Dexamethasone—ulcerative colitis	0.000269	0.000579	CcSEcCtD
Orlistat—Anxiety—Betamethasone—ulcerative colitis	0.000268	0.000577	CcSEcCtD
Orlistat—Anxiety—Dexamethasone—ulcerative colitis	0.000268	0.000577	CcSEcCtD
Orlistat—Rash—Mesalazine—ulcerative colitis	0.000267	0.000576	CcSEcCtD
Orlistat—Dermatitis—Mesalazine—ulcerative colitis	0.000267	0.000576	CcSEcCtD
Orlistat—PNLIP—Metabolism—PTGS1—ulcerative colitis	0.000266	0.00117	CbGpPWpGaD
Orlistat—Headache—Mesalazine—ulcerative colitis	0.000265	0.000573	CcSEcCtD
Orlistat—Discomfort—Dexamethasone—ulcerative colitis	0.000265	0.000572	CcSEcCtD
Orlistat—Discomfort—Betamethasone—ulcerative colitis	0.000265	0.000572	CcSEcCtD
Orlistat—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000265	0.000572	CcSEcCtD
Orlistat—Pain—Prednisolone—ulcerative colitis	0.000264	0.000569	CcSEcCtD
Orlistat—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000262	0.000565	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000262	0.00115	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00026	0.000561	CcSEcCtD
Orlistat—Fatigue—Hydrocortisone—ulcerative colitis	0.00026	0.00056	CcSEcCtD
Orlistat—Vision blurred—Prednisone—ulcerative colitis	0.000259	0.000558	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000259	0.000557	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000258	0.000556	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—GNA12—ulcerative colitis	0.000258	0.00113	CbGpPWpGaD
Orlistat—Pain—Hydrocortisone—ulcerative colitis	0.000258	0.000556	CcSEcCtD
Orlistat—Oedema—Dexamethasone—ulcerative colitis	0.000257	0.000555	CcSEcCtD
Orlistat—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000257	0.000555	CcSEcCtD
Orlistat—Oedema—Betamethasone—ulcerative colitis	0.000257	0.000555	CcSEcCtD
Orlistat—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000257	0.000555	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CCR6—ulcerative colitis	0.000257	0.00112	CbGpPWpGaD
Orlistat—Insomnia—Triamcinolone—ulcerative colitis	0.000257	0.000553	CcSEcCtD
Orlistat—Insomnia—Methylprednisolone—ulcerative colitis	0.000256	0.000552	CcSEcCtD
Orlistat—Infection—Betamethasone—ulcerative colitis	0.000256	0.000552	CcSEcCtD
Orlistat—Infection—Dexamethasone—ulcerative colitis	0.000256	0.000552	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisone—ulcerative colitis	0.000255	0.00055	CcSEcCtD
Orlistat—Paraesthesia—Triamcinolone—ulcerative colitis	0.000255	0.000549	CcSEcCtD
Orlistat—Feeling abnormal—Prednisolone—ulcerative colitis	0.000254	0.000548	CcSEcCtD
Orlistat—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000254	0.000548	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—ITGAL—ulcerative colitis	0.000253	0.00111	CbGpPWpGaD
Orlistat—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000252	0.000544	CcSEcCtD
Orlistat—Nervous system disorder—Betamethasone—ulcerative colitis	0.000252	0.000544	CcSEcCtD
Orlistat—Nausea—Mesalazine—ulcerative colitis	0.000252	0.000543	CcSEcCtD
Orlistat—Angioedema—Prednisone—ulcerative colitis	0.000251	0.000541	CcSEcCtD
Orlistat—Dyspepsia—Triamcinolone—ulcerative colitis	0.00025	0.000539	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—GHRL—ulcerative colitis	0.00025	0.00109	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GHRL—ulcerative colitis	0.00025	0.00109	CbGpPWpGaD
Orlistat—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000249	0.000537	CcSEcCtD
Orlistat—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000249	0.000537	CcSEcCtD
Orlistat—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000249	0.000537	CcSEcCtD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—JAK2—ulcerative colitis	0.000248	0.00109	CbGpPWpGaD
Orlistat—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000248	0.000536	CcSEcCtD
Orlistat—Malaise—Prednisone—ulcerative colitis	0.000248	0.000534	CcSEcCtD
Orlistat—Vertigo—Prednisone—ulcerative colitis	0.000247	0.000532	CcSEcCtD
Orlistat—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000246	0.000531	CcSEcCtD
Orlistat—FASN—Disease—MAML2—ulcerative colitis	0.000246	0.00108	CbGpPWpGaD
Orlistat—Urticaria—Prednisolone—ulcerative colitis	0.000245	0.000529	CcSEcCtD
Orlistat—Fatigue—Triamcinolone—ulcerative colitis	0.000245	0.000528	CcSEcCtD
Orlistat—Fatigue—Methylprednisolone—ulcerative colitis	0.000244	0.000526	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—MAML2—ulcerative colitis	0.000243	0.00107	CbGpPWpGaD
Orlistat—Pain—Triamcinolone—ulcerative colitis	0.000243	0.000523	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—CALM3—ulcerative colitis	0.000242	0.00106	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CALM3—ulcerative colitis	0.000242	0.00106	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CALM3—ulcerative colitis	0.00024	0.00105	CbGpPWpGaD
Orlistat—Urticaria—Hydrocortisone—ulcerative colitis	0.000239	0.000516	CcSEcCtD
Orlistat—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000238	0.000514	CcSEcCtD
Orlistat—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000238	0.000514	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—RIPK2—ulcerative colitis	0.000238	0.00104	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RIPK2—ulcerative colitis	0.000238	0.00104	CbGpPWpGaD
Orlistat—Convulsion—Prednisone—ulcerative colitis	0.000238	0.000513	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000235	0.000506	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000235	0.000506	CcSEcCtD
Orlistat—Myalgia—Prednisone—ulcerative colitis	0.000234	0.000504	CcSEcCtD
Orlistat—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000234	0.000504	CcSEcCtD
Orlistat—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000233	0.000503	CcSEcCtD
Orlistat—Anxiety—Prednisone—ulcerative colitis	0.000233	0.000503	CcSEcCtD
Orlistat—Insomnia—Dexamethasone—ulcerative colitis	0.000233	0.000502	CcSEcCtD
Orlistat—Insomnia—Betamethasone—ulcerative colitis	0.000233	0.000502	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000232	0.000501	CcSEcCtD
Orlistat—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000231	0.000499	CcSEcCtD
Orlistat—Paraesthesia—Dexamethasone—ulcerative colitis	0.000231	0.000499	CcSEcCtD
Orlistat—Paraesthesia—Betamethasone—ulcerative colitis	0.000231	0.000499	CcSEcCtD
Orlistat—Discomfort—Prednisone—ulcerative colitis	0.000231	0.000498	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000229	0.001	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisolone—ulcerative colitis	0.000227	0.00049	CcSEcCtD
Orlistat—Dyspepsia—Dexamethasone—ulcerative colitis	0.000227	0.000489	CcSEcCtD
Orlistat—Dyspepsia—Betamethasone—ulcerative colitis	0.000227	0.000489	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—PTGER4—ulcerative colitis	0.000226	0.000989	CbGpPWpGaD
Orlistat—Urticaria—Triamcinolone—ulcerative colitis	0.000225	0.000486	CcSEcCtD
Orlistat—Urticaria—Methylprednisolone—ulcerative colitis	0.000225	0.000485	CcSEcCtD
Orlistat—Body temperature increased—Triamcinolone—ulcerative colitis	0.000224	0.000484	CcSEcCtD
Orlistat—Oedema—Prednisone—ulcerative colitis	0.000224	0.000484	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisone—ulcerative colitis	0.000224	0.000484	CcSEcCtD
Orlistat—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000224	0.000483	CcSEcCtD
Orlistat—Decreased appetite—Dexamethasone—ulcerative colitis	0.000224	0.000483	CcSEcCtD
Orlistat—Decreased appetite—Betamethasone—ulcerative colitis	0.000224	0.000483	CcSEcCtD
Orlistat—Infection—Prednisone—ulcerative colitis	0.000223	0.00048	CcSEcCtD
Orlistat—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000222	0.000479	CcSEcCtD
Orlistat—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000222	0.000479	CcSEcCtD
Orlistat—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000222	0.000479	CcSEcCtD
Orlistat—Fatigue—Dexamethasone—ulcerative colitis	0.000222	0.000479	CcSEcCtD
Orlistat—Fatigue—Betamethasone—ulcerative colitis	0.000222	0.000479	CcSEcCtD
Orlistat—Pain—Dexamethasone—ulcerative colitis	0.00022	0.000475	CcSEcCtD
Orlistat—Pain—Betamethasone—ulcerative colitis	0.00022	0.000475	CcSEcCtD
Orlistat—Nervous system disorder—Prednisone—ulcerative colitis	0.00022	0.000474	CcSEcCtD
Orlistat—DAGLB—Hemostasis—TGFB1—ulcerative colitis	0.000219	0.000961	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—ulcerative colitis	0.000219	0.000961	CbGpPWpGaD
Orlistat—Skin disorder—Prednisone—ulcerative colitis	0.000218	0.00047	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisone—ulcerative colitis	0.000217	0.000467	CcSEcCtD
Orlistat—Asthenia—Hydrocortisone—ulcerative colitis	0.000216	0.000466	CcSEcCtD
Orlistat—Pruritus—Hydrocortisone—ulcerative colitis	0.000213	0.00046	CcSEcCtD
Orlistat—Feeling abnormal—Betamethasone—ulcerative colitis	0.000212	0.000458	CcSEcCtD
Orlistat—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000212	0.000458	CcSEcCtD
Orlistat—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000211	0.000454	CcSEcCtD
Orlistat—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000211	0.000454	CcSEcCtD
Orlistat—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000209	0.000451	CcSEcCtD
Orlistat—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000209	0.00045	CcSEcCtD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000208	0.000912	CbGpPWpGaD
Orlistat—PNLIP—Disease—ADCY5—ulcerative colitis	0.000208	0.000909	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GHRL—ulcerative colitis	0.000207	0.000906	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ADRB2—ulcerative colitis	0.000207	0.000905	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ADRB2—ulcerative colitis	0.000207	0.000905	CbGpPWpGaD
Orlistat—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000206	0.000445	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000206	0.000902	CbGpPWpGaD
Orlistat—Urticaria—Dexamethasone—ulcerative colitis	0.000205	0.000441	CcSEcCtD
Orlistat—Urticaria—Betamethasone—ulcerative colitis	0.000205	0.000441	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000204	0.000441	CcSEcCtD
Orlistat—Dizziness—Prednisolone—ulcerative colitis	0.000204	0.00044	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—JAK2—ulcerative colitis	0.000204	0.000893	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—JAK2—ulcerative colitis	0.000204	0.000893	CbGpPWpGaD
Orlistat—Asthenia—Triamcinolone—ulcerative colitis	0.000204	0.000439	CcSEcCtD
Orlistat—Abdominal pain—Dexamethasone—ulcerative colitis	0.000204	0.000439	CcSEcCtD
Orlistat—Abdominal pain—Betamethasone—ulcerative colitis	0.000204	0.000439	CcSEcCtD
Orlistat—Body temperature increased—Dexamethasone—ulcerative colitis	0.000204	0.000439	CcSEcCtD
Orlistat—Body temperature increased—Betamethasone—ulcerative colitis	0.000204	0.000439	CcSEcCtD
Orlistat—Asthenia—Methylprednisolone—ulcerative colitis	0.000203	0.000438	CcSEcCtD
Orlistat—Insomnia—Prednisone—ulcerative colitis	0.000203	0.000437	CcSEcCtD
Orlistat—FASN—Disease—CALM3—ulcerative colitis	0.000202	0.000886	CbGpPWpGaD
Orlistat—Paraesthesia—Prednisone—ulcerative colitis	0.000201	0.000434	CcSEcCtD
Orlistat—Pruritus—Triamcinolone—ulcerative colitis	0.000201	0.000433	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CALM3—ulcerative colitis	0.0002	0.000877	CbGpPWpGaD
Orlistat—Pruritus—Methylprednisolone—ulcerative colitis	0.0002	0.000432	CcSEcCtD
Orlistat—Dizziness—Hydrocortisone—ulcerative colitis	0.000199	0.00043	CcSEcCtD
Orlistat—Dyspepsia—Prednisone—ulcerative colitis	0.000197	0.000426	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—RIPK2—ulcerative colitis	0.000197	0.000864	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000197	0.000863	CbGpPWpGaD
Orlistat—Decreased appetite—Prednisone—ulcerative colitis	0.000195	0.00042	CcSEcCtD
Orlistat—Rash—Prednisolone—ulcerative colitis	0.000195	0.00042	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—ulcerative colitis	0.000194	0.000419	CcSEcCtD
Orlistat—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000194	0.000418	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—CHP1—ulcerative colitis	0.000194	0.000848	CbGpPWpGaD
Orlistat—Fatigue—Prednisone—ulcerative colitis	0.000193	0.000417	CcSEcCtD
Orlistat—Headache—Prednisolone—ulcerative colitis	0.000193	0.000417	CcSEcCtD
Orlistat—Vomiting—Hydrocortisone—ulcerative colitis	0.000192	0.000413	CcSEcCtD
Orlistat—Rash—Hydrocortisone—ulcerative colitis	0.00019	0.00041	CcSEcCtD
Orlistat—Dermatitis—Hydrocortisone—ulcerative colitis	0.00019	0.000409	CcSEcCtD
Orlistat—Headache—Hydrocortisone—ulcerative colitis	0.000189	0.000407	CcSEcCtD
Orlistat—FASN—Metabolism—PTGS1—ulcerative colitis	0.000188	0.000824	CbGpPWpGaD
Orlistat—Dizziness—Triamcinolone—ulcerative colitis	0.000188	0.000405	CcSEcCtD
Orlistat—Dizziness—Methylprednisolone—ulcerative colitis	0.000187	0.000404	CcSEcCtD
Orlistat—PNLIP—Metabolism—ABCB1—ulcerative colitis	0.000186	0.000816	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000186	0.000815	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000186	0.000815	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000185	0.000811	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—JAK2—ulcerative colitis	0.000185	0.000811	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—JAK2—ulcerative colitis	0.000185	0.000811	CbGpPWpGaD
Orlistat—Feeling abnormal—Prednisone—ulcerative colitis	0.000185	0.000398	CcSEcCtD
Orlistat—Asthenia—Dexamethasone—ulcerative colitis	0.000185	0.000398	CcSEcCtD
Orlistat—Asthenia—Betamethasone—ulcerative colitis	0.000185	0.000398	CcSEcCtD
Orlistat—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000183	0.000395	CcSEcCtD
Orlistat—Nausea—Prednisolone—ulcerative colitis	0.000183	0.000395	CcSEcCtD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—STAT3—ulcerative colitis	0.000182	0.000798	CbGpPWpGaD
Orlistat—Pruritus—Betamethasone—ulcerative colitis	0.000182	0.000393	CcSEcCtD
Orlistat—Pruritus—Dexamethasone—ulcerative colitis	0.000182	0.000393	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000181	0.000794	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—ulcerative colitis	0.000181	0.000791	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—ulcerative colitis	0.000181	0.000791	CbGpPWpGaD
Orlistat—Vomiting—Triamcinolone—ulcerative colitis	0.00018	0.000389	CcSEcCtD
Orlistat—Vomiting—Methylprednisolone—ulcerative colitis	0.00018	0.000388	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—CALM3—ulcerative colitis	0.000179	0.000786	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000179	0.000785	CbGpPWpGaD
Orlistat—Nausea—Hydrocortisone—ulcerative colitis	0.000179	0.000386	CcSEcCtD
Orlistat—Rash—Triamcinolone—ulcerative colitis	0.000179	0.000386	CcSEcCtD
Orlistat—Dermatitis—Triamcinolone—ulcerative colitis	0.000179	0.000385	CcSEcCtD
Orlistat—Rash—Methylprednisolone—ulcerative colitis	0.000179	0.000385	CcSEcCtD
Orlistat—Dermatitis—Methylprednisolone—ulcerative colitis	0.000178	0.000385	CcSEcCtD
Orlistat—Urticaria—Prednisone—ulcerative colitis	0.000178	0.000384	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—IL2—ulcerative colitis	0.000178	0.000779	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL2—ulcerative colitis	0.000178	0.000779	CbGpPWpGaD
Orlistat—Headache—Triamcinolone—ulcerative colitis	0.000178	0.000383	CcSEcCtD
Orlistat—Headache—Methylprednisolone—ulcerative colitis	0.000177	0.000382	CcSEcCtD
Orlistat—Body temperature increased—Prednisone—ulcerative colitis	0.000177	0.000382	CcSEcCtD
Orlistat—Abdominal pain—Prednisone—ulcerative colitis	0.000177	0.000382	CcSEcCtD
Orlistat—Diarrhoea—Betamethasone—ulcerative colitis	0.000176	0.00038	CcSEcCtD
Orlistat—Diarrhoea—Dexamethasone—ulcerative colitis	0.000176	0.00038	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—ADCY5—ulcerative colitis	0.000175	0.000768	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ADCY5—ulcerative colitis	0.000175	0.000768	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ADCY5—ulcerative colitis	0.000174	0.000761	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADRB2—ulcerative colitis	0.000171	0.00075	CbGpPWpGaD
Orlistat—Dizziness—Dexamethasone—ulcerative colitis	0.00017	0.000367	CcSEcCtD
Orlistat—Dizziness—Betamethasone—ulcerative colitis	0.00017	0.000367	CcSEcCtD
Orlistat—FASN—Metabolism—CALM3—ulcerative colitis	0.00017	0.000742	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000169	0.000741	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—ulcerative colitis	0.000169	0.00074	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—ulcerative colitis	0.000169	0.00074	CbGpPWpGaD
Orlistat—Nausea—Triamcinolone—ulcerative colitis	0.000169	0.000363	CcSEcCtD
Orlistat—Nausea—Methylprednisolone—ulcerative colitis	0.000168	0.000363	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—DLD—ulcerative colitis	0.000167	0.000732	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000166	0.000729	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisone—ulcerative colitis	0.000165	0.000356	CcSEcCtD
Orlistat—Vomiting—Dexamethasone—ulcerative colitis	0.000164	0.000353	CcSEcCtD
Orlistat—Vomiting—Betamethasone—ulcerative colitis	0.000164	0.000353	CcSEcCtD
Orlistat—Rash—Dexamethasone—ulcerative colitis	0.000162	0.00035	CcSEcCtD
Orlistat—Rash—Betamethasone—ulcerative colitis	0.000162	0.00035	CcSEcCtD
Orlistat—Dermatitis—Betamethasone—ulcerative colitis	0.000162	0.00035	CcSEcCtD
Orlistat—Dermatitis—Dexamethasone—ulcerative colitis	0.000162	0.00035	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000162	0.000709	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL2—ulcerative colitis	0.000161	0.000707	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL2—ulcerative colitis	0.000161	0.000707	CbGpPWpGaD
Orlistat—Headache—Betamethasone—ulcerative colitis	0.000161	0.000348	CcSEcCtD
Orlistat—Headache—Dexamethasone—ulcerative colitis	0.000161	0.000348	CcSEcCtD
Orlistat—Asthenia—Prednisone—ulcerative colitis	0.000161	0.000347	CcSEcCtD
Orlistat—Pruritus—Prednisone—ulcerative colitis	0.000159	0.000342	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000157	0.000689	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL20—ulcerative colitis	0.000157	0.000689	CbGpPWpGaD
Orlistat—Diarrhoea—Prednisone—ulcerative colitis	0.000153	0.000331	CcSEcCtD
Orlistat—Nausea—Betamethasone—ulcerative colitis	0.000153	0.00033	CcSEcCtD
Orlistat—Nausea—Dexamethasone—ulcerative colitis	0.000153	0.00033	CcSEcCtD
Orlistat—Dizziness—Prednisone—ulcerative colitis	0.000148	0.00032	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—GNA12—ulcerative colitis	0.000148	0.000648	CbGpPWpGaD
Orlistat—FASN—Disease—ADCY5—ulcerative colitis	0.000147	0.000643	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADCY5—ulcerative colitis	0.000145	0.000636	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000145	0.000633	CbGpPWpGaD
Orlistat—Vomiting—Prednisone—ulcerative colitis	0.000143	0.000307	CcSEcCtD
Orlistat—Rash—Prednisone—ulcerative colitis	0.000141	0.000305	CcSEcCtD
Orlistat—Dermatitis—Prednisone—ulcerative colitis	0.000141	0.000305	CcSEcCtD
Orlistat—Headache—Prednisone—ulcerative colitis	0.00014	0.000303	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR2—ulcerative colitis	0.00014	0.000614	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.000137	0.000601	CbGpPWpGaD
Orlistat—Nausea—Prednisone—ulcerative colitis	0.000133	0.000287	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CCR6—ulcerative colitis	0.000132	0.000578	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCB1—ulcerative colitis	0.000132	0.000577	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARG—ulcerative colitis	0.00013	0.000568	CbGpPWpGaD
Orlistat—PNLIP—Disease—JAK2—ulcerative colitis	0.000129	0.000567	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SEL1L—ulcerative colitis	0.000129	0.000563	CbGpPWpGaD
Orlistat—FASN—Metabolism—ADCY5—ulcerative colitis	0.000123	0.000538	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD4—ulcerative colitis	0.000123	0.000537	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—ulcerative colitis	0.000122	0.000533	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.00012	0.000527	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ALB—ulcerative colitis	0.000117	0.00051	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000116	0.000508	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MMP1—ulcerative colitis	0.000115	0.000504	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000112	0.000492	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000111	0.000484	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—JAK2—ulcerative colitis	0.000109	0.000479	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—JAK2—ulcerative colitis	0.000109	0.000479	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000107	0.000469	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GHRL—ulcerative colitis	0.000106	0.000466	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RELA—ulcerative colitis	0.000106	0.000464	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RELA—ulcerative colitis	0.000106	0.000464	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR1—ulcerative colitis	0.000106	0.000464	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CALM3—ulcerative colitis	0.000103	0.000451	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—ulcerative colitis	0.000102	0.000447	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—ulcerative colitis	9.98e-05	0.000437	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—ulcerative colitis	9.98e-05	0.000437	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.91e-05	0.000434	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—ulcerative colitis	9.54e-05	0.000418	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—ulcerative colitis	9.54e-05	0.000418	CbGpPWpGaD
Orlistat—PNLIP—Disease—STAT3—ulcerative colitis	9.5e-05	0.000416	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—ulcerative colitis	9.49e-05	0.000416	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—ulcerative colitis	9.49e-05	0.000416	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL20—ulcerative colitis	9.3e-05	0.000407	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—ulcerative colitis	9.17e-05	0.000402	CbGpPWpGaD
Orlistat—FASN—Disease—JAK2—ulcerative colitis	9.16e-05	0.000401	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—JAK2—ulcerative colitis	9.06e-05	0.000397	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—ulcerative colitis	9.03e-05	0.000395	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—ulcerative colitis	9.03e-05	0.000395	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NFKB1—ulcerative colitis	8.93e-05	0.000391	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NFKB1—ulcerative colitis	8.93e-05	0.000391	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.84e-05	0.000387	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—ulcerative colitis	8.8e-05	0.000385	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADRB2—ulcerative colitis	8.8e-05	0.000385	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RELA—ulcerative colitis	8.78e-05	0.000384	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GNA12—ulcerative colitis	8.74e-05	0.000383	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—ulcerative colitis	8.73e-05	0.000382	CbGpPWpGaD
Orlistat—FASN—Disease—CD4—ulcerative colitis	8.68e-05	0.00038	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—ulcerative colitis	8.62e-05	0.000377	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR2—ulcerative colitis	8.29e-05	0.000363	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—ulcerative colitis	8.27e-05	0.000362	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—ulcerative colitis	8.25e-05	0.000361	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—JAK2—ulcerative colitis	8.12e-05	0.000355	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS1—ulcerative colitis	8.08e-05	0.000354	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—STAT3—ulcerative colitis	8.03e-05	0.000351	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—STAT3—ulcerative colitis	8.03e-05	0.000351	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.95e-05	0.000348	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—ulcerative colitis	7.9e-05	0.000346	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCR6—ulcerative colitis	7.79e-05	0.000341	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—ulcerative colitis	7.48e-05	0.000328	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADCY5—ulcerative colitis	7.47e-05	0.000327	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—ulcerative colitis	7.44e-05	0.000326	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—ulcerative colitis	7.44e-05	0.000326	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NFKB1—ulcerative colitis	7.4e-05	0.000324	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAML2—ulcerative colitis	7.39e-05	0.000323	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CALM3—ulcerative colitis	7.27e-05	0.000319	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—ulcerative colitis	7.22e-05	0.000316	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—ulcerative colitis	7.08e-05	0.00031	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.95e-05	0.000304	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTGER4—ulcerative colitis	6.86e-05	0.0003	CbGpPWpGaD
Orlistat—FASN—Disease—STAT3—ulcerative colitis	6.72e-05	0.000294	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—STAT3—ulcerative colitis	6.65e-05	0.000291	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—ulcerative colitis	6.63e-05	0.00029	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GHRL—ulcerative colitis	6.28e-05	0.000275	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—ulcerative colitis	6.23e-05	0.000273	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—ulcerative colitis	6.17e-05	0.00027	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—ulcerative colitis	6.13e-05	0.000268	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—ulcerative colitis	6.13e-05	0.000268	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CALM3—ulcerative colitis	6.08e-05	0.000266	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RIPK2—ulcerative colitis	5.99e-05	0.000262	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCB1—ulcerative colitis	5.66e-05	0.000248	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—ulcerative colitis	5.61e-05	0.000245	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—ulcerative colitis	5.61e-05	0.000245	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—ulcerative colitis	5.52e-05	0.000242	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADCY5—ulcerative colitis	5.28e-05	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB2—ulcerative colitis	5.2e-05	0.000228	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—ulcerative colitis	5.08e-05	0.000222	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—ulcerative colitis	4.69e-05	0.000206	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—JAK2—ulcerative colitis	4.66e-05	0.000204	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—ulcerative colitis	4.65e-05	0.000203	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—ulcerative colitis	4.55e-05	0.000199	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.53e-05	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADCY5—ulcerative colitis	4.41e-05	0.000193	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—ulcerative colitis	4.25e-05	0.000186	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—ulcerative colitis	4.06e-05	0.000178	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—ulcerative colitis	3.94e-05	0.000172	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DLD—ulcerative colitis	3.91e-05	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—ulcerative colitis	3.54e-05	0.000155	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—ulcerative colitis	3.1e-05	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAK2—ulcerative colitis	2.75e-05	0.00012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RELA—ulcerative colitis	2.66e-05	0.000117	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—ulcerative colitis	2.51e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—ulcerative colitis	2.4e-05	0.000105	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—ulcerative colitis	2.39e-05	0.000105	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—ulcerative colitis	2.27e-05	9.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKB1—ulcerative colitis	2.25e-05	9.84e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT3—ulcerative colitis	2.02e-05	8.84e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.89e-05	8.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—ulcerative colitis	1.87e-05	8.2e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.7e-05	7.46e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—ulcerative colitis	1.54e-05	6.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—ulcerative colitis	1.41e-05	6.18e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.32e-05	5.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.24e-05	5.41e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.22e-06	4.04e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—ulcerative colitis	8.29e-06	3.63e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.25e-06	3.17e-05	CbGpPWpGaD
